Mark Kankel

Mark Kankel has a vast work experience starting as a PhD student at Washington University in St. Louis, where they studied embryonic development in Drosophila. Mark then moved on to roles at Harvard Medical School, Genzyme Genetics, Harvard Medical School again, Biogen Idec, and currently at ATP (Apple Tree Partners) as the Head of ATP Research Labs. Throughout their career, Mark has focused on researching neurodegenerative diseases, specifically Parkinson's Disease and Amyotrophic Lateral Sclerosis, using genetic approaches and cell culture models. Additionally, they have been involved in target validation, drug discovery programs, and technical lead roles in various projects related to genetic mutations and disease monitoring.

Mark Kankel attended North Haven High School before earning a Bachelor of Science degree in Math and History from the University of Wisconsin-Madison. Mark then went on to obtain a Ph.D. in Developmental Genetics from Washington University School of Medicine in St. Louis. There is no specific information provided about their time at Washington University in St. Louis.